Goliath and David
June 24, 2020Bayer AG
July 10, 2020Food Chain Radio Show #1236
Michael Olson, Author & Urban Farming Agriculturalist
Glyphosate and Covid-19?
Guest: Dr. Stephanie Seneff, Senior Research Scientist, MIT’s Computer Science and Artificial Intelligence Laboratory
When the German pharmaceutical giant Bayer purchased the U.S. seed company Monsanto for $63 billion dollars, many wondered why?
After all, the patent on Monsanto’s principal money-making product, the weed-killing herbicide trade-named Roundup, has expired and its active ingredient, glyphosate, is now available for anyone to bottle and sell.
And, plants that previously had been killed by glyphosate were developing an immunity to the chemical, and resistant super-weeds were popping up in farmlands across the nation.
Furthermore, farmers themselves were complaining of sicknesses like non-Hodgkin Lymphoma, and pointing their fingers at glyphosate as the cause. And Bayer, though admitting no guilt, has agreed to pay $10 billion dollars to settle the farmers’ glyphosate lawsuits.
Given all the negatives, little wonder then why people scratch their heads at the wisdom of Bayer buying Monsanto. Why bother? Perhaps Bayer knows the extent to which industrial agriculture has come to rely on glyphosate, and how difficult it will be to do business without the weed-killing pesticide.
And so, one can safely assume that Bayer is confident that glyphosate will continue to be ubiquitous in the environment. And that leads some to wonder to what effect, and for one to ask….
Leave a comment below: Is there a connection between glyphosate and the Covid-19 coronavirus?